August 12th 2026
The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra
DDA news Dispensary guidance news
August 12th 2026
The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ
DDA news Research
August 12th 2026
The DDA has described the response of Sanofi to a batch loss said to affect two million flu vaccines as “simply not good enough” In October 2025, Sanofi negotiated a bulk purchase deal for DDA members, offering a £3 discount on flu
Clinical guidance news Supply Shortages
August 11th 2026
The UK has become the first country in Europe to authorise Eli Lilly’s GLP-1 receptor agonist tablet orforglipron for weight management and type 2 diabetes. While this tablet is approved for use in the UK, it is not a
Clinical guidance news MHRA
August 6th 2026
Eight more products will move from Category C to Category H, effective from September 2026, the Department of Health has announced. Pack sizes and prices will be announced in the September Drug Tariff for England and Wales three working d
DM Zone news Drug Tariff Updates England Wales
August 5th 2026
In this new podcast, we put DDA Chief Executive Matthew Isom on the spot over a recent question to our DDA Best Practice Facebook group on PA and VAT. You can also find out why we might be supplying you with eggs and flour in the free breakout sessi
Conference news DDA news Political News
NHS digitisation/electronic prescription services 
Pharmaceutical Needs Assessments 
Reimbursement 
Clawback 
Branded generics 
Remuneration - rurality 
